BayBridge Capital Group’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$639K Buy
2,438
+1,114
+84% +$294K 0.34% 75
2026
Q2
$292K Buy
1,324
+384
+41% +$106K 0.15% 88
2026
Q1
$257K Hold
940
– – 0.16% 87
2025
Q4
$257K Buy
940
+39
+4% +$10.6K 0.16% 87
2025
Q3
$243K Buy
+901
New +$245K 0.16% 87

Other funds holding CME

BayBridge Capital Group's CME Position: Q3 2026 in Review

BayBridge Capital Group increased its CME Group (CME) stake by 84% in Q3 2026, buying an estimated $294K and bringing the position to 2,438 shares worth $639K. The position accounts for 0.34% of the portfolio, ranked #75.

BayBridge Capital Group first reported a position in CME in Q3 2025 and has held it in 5 quarters since. 1,768 funds tracked by Wall St. Rank hold CME as of Q3 2026.

  • BayBridge Capital Group held 2,438 shares of CME Group worth $639K as of Q3 2026.
  • BayBridge Capital Group bought 1,114 CME Group shares in Q3 2026, an estimated $294K.
  • CME Group made up 0.34% of BayBridge Capital Group's portfolio in Q3 2026, its #75 holding.
  • BayBridge Capital Group first reported a position in CME Group in Q3 2025 and has held it in 5 quarters since.
  • 1,768 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on BayBridge Capital Group's 13F filing for Q3 2026, filed 13 Oct 2026.